PCV21 A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME

✍ Scribed by GF Guzauskas; D Veenstra; D Hughes

• Book ID: 118610425
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 97 KB
• Volume: 13
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)72741-8